Casipong, Angelito, Jr. B.

HRN: 25-30-07  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/16/2024
MUPIROCIN 2%, 15G (TUBE)
06/16/2024
06/23/2024
TOPICAL
1
Tid
IV Site Infection
Waiting Final Action 
06/17/2024
CEFUROXIME 750MG (VIAL)
06/17/2024
06/23/2024
IV
240mg
Q8
Acute Bacterial Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: